Holen Sie sich die Stockscreener-App
0.3372
5.39%
-0.0192
Handel nachbörslich:
.34
0.0028
+0.83%
Schlusskurs vom Vortag:
$0.3564
Offen:
$0.35
24-Stunden-Volumen:
561.68K
Relative Volume:
1.14
Marktkapitalisierung:
$10.01M
Einnahmen:
$4.03M
Nettoeinkommen (Verlust:
$24.32M
KGV:
-0.0784
EPS:
-4.3008
Netto-Cashflow:
$-45.76M
1W Leistung:
+5.37%
1M Leistung:
-29.76%
6M Leistung:
-46.49%
1J Leistung:
-66.61%
1-Tages-Spanne:
$0.327
$0.3562
1-Wochen-Bereich:
$0.327
$0.4399
52-Wochen-Spanne:
$0.304
$1.25
Pavmed Inc Stock (PAVM) Company Profile
Firmenname
Pavmed Inc
Sektor
Branche
Telefon
(212) 949-4319
Adresse
360 MADISON AVENUE, NEW YORK, NY
Vergleichen Sie PAVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.3372 | 9.85M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Eingeleitet | Maxim Group | Buy |
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
What analysts say about PAVmed Inc stockPrice Channel Trading & Small Investment Capital Tips - earlytimes.in
Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus - MSN
Will PAVmed Inc. stock benefit from upcoming earnings reports2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
GenomeWeb Names Lucid Diagnostics (Nasdaq: LUCD) 2025 Best Places to Work Honoree - Stock Titan
Will PAVmed Inc. stock deliver strong dividend growthStop Loss & Weekly Top Stock Performers List - newser.com
Is PAVmed Inc. stock ready for breakoutPortfolio Gains Report & Community Driven Trade Alerts - newser.com
Is PAVmed Inc. stock cheap at current valuationJuly 2025 Gainers & Consistent Growth Equity Picks - newser.com
Combining machine learning predictions for PAVmed Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Why retail investors pile into PAVmed Inc. stock2025 Top Gainers & High Yield Stock Recommendations - newser.com
Should I hold or sell PAVmed Inc. stock in 20252025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com
PAVmed Inc. (NASDAQ:PAVM) Q3 2025 Earnings Call Transcript - MSN
Is PAVmed (NASDAQ:PAVM) Using Debt Sensibly? - simplywall.st
PAVmed Inc. (PAVMW) AI-Powered Stock Analysis - Meyka
Candlestick signals on PAVmed Inc. stock today2025 Investor Takeaways & Real-Time Chart Breakout Alerts - newser.com
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Detecting support and resistance levels for PAVmed Inc.Market Growth Summary & Weekly Top Gainers Trade List - newser.com
PAVmed Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:PAVM) 2025-11-14 - Seeking Alpha
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Eastern Progress
Why PAVmed Inc. is moving todayEarnings Summary Report & Consistent Income Trade Recommendations - newser.com
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... By GuruFocus - Investing.com Canada
Lucid Diagnostics Gains Medicare Support for EsoGuard - MSN
How PAVmed Inc. stock performs during Fed tightening cyclesWeekly Stock Summary & Community Driven Trade Alerts - newser.com
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Pa - GuruFocus
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Earnings call transcript: PAVmed Q3 2025 reports net loss, stock dips - Investing.com Nigeria
Transcript : PAVmed Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener
PAVmed Announces Q3 2025 Financial Results and Updates - TipRanks
PAVmed Inc. (PAVM) Q3 FY2025 earnings call transcript - Yahoo Finance
[8-K] PAVmed Inc. Reports Material Event - Stock Titan
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results - Eastern Progress
PAVM: Q3 2025 saw $1.2M revenue, $10.4M net loss, and strong cash position after a $27M offering - TradingView
Finanzdaten der Pavmed Inc-Aktie (PAVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):